Top of page
Health

Cycles of Reward: New Insight into ADHD Treatment

girl with ADHD playing

Attention-Deficit Hyperactivity Disorder (ADHD) is a widespread condition with complex underlying causes. A stimulant drug called methylphenidate is a common ADHD treatment that impacts the brain’s levels of dopamine, a neurotransmitter involved in systems of reward; however, methylphenidate has a potential for abuse, and its therapeutic effects are poorly understood.

To explore methylphenidate’s varied interactions with dopamine systems in the brain, researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats. Using dopamine cell recordings, electrochemical monitoring and computer modeling, they discovered a type of feedback loop that modulates dopamine levels in the rats’ brains in response to the drug. This regulatory process may shed light on methylphenidate’s therapeutic properties in ADHD. The researchers’ findings are published in Progress in Neurobiology.

“We know quite a bit about how methylphenidate works at the molecular level, but not how it affects greater neural systems. It’s still a mystery how this drug improves symptoms of ADHD,” said Professor Jeff Wickens of OIST’s Neurobiology Research Unit. “This mystery leads us to explore how different parts of the brain interact to produce therapeutic effects.”

To carry out their research, the international team administered methylphenidate at a concentration of 5.0 mg/kg to a group of adult male rats, while a control group received no drugs. After surgically implanting electrodes in the rats’ brains, the researchers used an electrochemical technique called voltammetry to monitor real-time changes in cellular dopamine concentration in brain regions involved in ADHD. The researchers also took measurements in live brain slices of rats’ midbrains and forebrains.

To help understand the data, the scientists at OIST, including technician Kavinda Liyanagama, designed a computer program to model the effects of methylphenidate on dopamine systems.

You might also like

Deaf patient use video conference, make online consultation by sign language with doctor on tablet Deaf patient use video conference, make online consultation by sign language with doctor on tablet

HHS and DOJ issue guidance on nondiscrimination in telehealth

The U.S. Department of Health and Human Services (HHS) and…

Woman silhouette with sun and clouds in her head Woman silhouette with sun and clouds in her head

Applications open for Diverse Communities Mental Health and Wellbeing Grants

Applications are now open for round two of the Diverse…

Close up of taking sample for coronavirus testing Close up of taking sample for coronavirus testing

Free RAT program for eligible Victorians with disability extended

The free rapid antigen tests program for eligible Victorians with…

The Yang-Tan Institute of Employment and Disability has joined a multi-institution team that has received a $5 million grant from the National Science Foundation (NSF) to help create better job outcomes for people with autism. The Yang-Tan Institute of Employment and Disability has joined a multi-institution team that has received a $5 million grant from the National Science Foundation (NSF) to help create better job outcomes for people with autism.

Research shows AI can improve stroke diagnostics

A new study presented on Thursday at the Society of…